Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « administered »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
adl < administered < administering  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]
Ident.Authors (with country if any)Title
000030 (2010) Katja Perdan-Pirkmajer [Slovénie] ; Sonja Praprotnik [Slovénie] ; Matija Tomši [Slovénie]A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature
000032 (2010) Daichi Inoue [Japon] ; Hiroshi Arima [Japon] ; Chiharu Kawanami [Japon] ; Yoko Takiuchi [Japon] ; Seiji Nagano [Japon] ; Takaharu Kimura [Japon] ; Sonoko Shimoji [Japon] ; Minako Mori [Japon] ; Sumie Tabata [Japon] ; Soshi Yanagita [Japon] ; Akiko Matsushita [Japon] ; Kenichi Nagai [Japon] ; Yukihiro Imai [Japon] ; Takayuki Takahashi [Japon]Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis
000043 (2009) Kazuko Matsumoto [Japon] ; Takao Nagashima [Japon] ; Shino Takatori [Japon] ; Yuta Kawahara [Japon] ; Masaki Yagi [Japon] ; Masahiro Iwamoto [Japon] ; Hitoaki Okazaki [Japon] ; Seiji Minota [Japon]Glucocorticoid and cyclosporine refractory adult onset Still’s disease successfully treated with tocilizumab
000049 (2012) Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France]Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
000060 (2013) Francesco Caso [Italie] ; Luca Iaccarino [Italie] ; Silvano Bettio [Italie] ; Francesca Ometto [Italie] ; Luisa Costa [Italie] ; Leonardo Punzi [Italie] ; Andrea Doria [Italie]Refractory pemphigus foliaceus and Behçet’s disease successfully treated with tocilizumab
000071 (2010) A. Gause [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H. Michels [Allemagne] ; M. Gaubitz [Allemagne] ; W.-J. Mayet [Allemagne]Empfehlungen der Deutschen Gesellschaft für Rheumatologie zum Einsatz von Tocilizumab bei der rheumatoiden Arthritis (Februar 2010)
000074 (2010) Keiichi Sumida [Japon] ; Yoshifumi Ubara [Japon] ; Junichi Hoshino [Japon] ; Tatsuya Suwabe [Japon] ; Rikako Hiramatsu [Japon] ; Eiko Hasegawa [Japon] ; Noriko Hayami [Japon] ; Masayuki Yamanouchi [Japon] ; Naoki Sawa [Japon] ; Fumi Takemoto [Japon] ; Kenmei Takaichi [Japon]Etanercept-refractory adult-onset Still’s disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab
000085 (2011) Hiroki Wakabayashi [Japon] ; Akihiro Sudo [Japon] ; Yosuke Nishioka [Japon] ; Masahiro Hasegawa [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon]Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis
000102 (2011) Masahiko Suzuki [Japon] ; Keiichiro Nishida [Japon] ; Satoshi Soen [Japon] ; Hiromi Oda [Japon] ; Hiroshi Inoue [Japon] ; Atsushi Kaneko [Japon] ; Kenji Takagishi [Japon] ; Takaaki Tanaka [Japon] ; Tsukasa Matsubara [Japon] ; Naoto Mitsugi [Japon] ; Yuichi Mochida [Japon] ; Shigeki Momohara [Japon] ; Toshihito Mori [Japon] ; Toru Suguro [Japon]Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association
000150 (2012) O. Psenak [Autriche] ; A. Studnicka-Benke [Autriche] ; R. Greil [Autriche]Sicherheit der Immunsuppressiva
000201 (2014) Kosmas Kretsos [Royaume-Uni] ; Georg Golor [Allemagne] ; Astrid Jullion [Belgique] ; Matthew Hickling [Royaume-Uni] ; Suzanne Mccabe [Belgique] ; Stevan Shaw [Royaume-Uni] ; Joby Jose [Royaume-Uni] ; Ruth Oliver [Royaume-Uni]Safety and pharmacokinetics of olokizumab, an anti‐IL‐6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I study
000304 (2013) Tomokazu Nagao ; Reina Kusunoki ; Chiaki Iwamura ; Shigeto Kobayashi ; Wako Yumura ; Yosuke Kameoka [Japon] ; Toshinori Nakayama ; Kazuo Suzuki [Japon]Correlation of interleukin‐6 and monocyte chemotactic protein‐1 concentrations with crescent formation and myeloperoxidase‐specific anti‐neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti‐interleukin‐6 receptor antibody or mizoribine
000421 (2013) P. N. Morcos [États-Unis] ; S. A. Moreira [États-Unis] ; B. J. Brennan [États-Unis] ; S. Blotner [États-Unis] ; N. S. Shulman [États-Unis] ; P. F. Smith [États-Unis]Influence of chronic hepatitis C infection on cytochrome P450 3a4 activity using midazolam as an in vivo probe substrate
000454 (2010) Takeshi Kuroda [Japon] ; Yoko Wada [Japon] ; Daisuke Kobayashi [Japon] ; Hiroe Sato [Japon] ; Syuichi Murakami [Japon] ; Masaaki Nakano [Japon] ; Ichiei Narita [Japon]Effect of etanercept and entecavil in a patient with rheumatoid arthritis who is a hepatitis B carrier: a review of the literature
000520 (2013) C. Carnovale [Italie] ; V. Perrone [Italie] ; C. Borsadoli [Italie] ; A. Mambrini [Italie] ; A. Speziali [Italie] ; G. Froldi [Italie] ; S. Antoniazzi [Italie] ; L. Magistro [Italie] ; E. Clementi [Italie] ; S. Radice [Italie]A case of urinary incontinence by hydroxychloroquine in a geriatric patient
000577 (2013) G.-R. Burmester [Allemagne] ; U. Von Hinüber ; C. Richter [Allemagne] ; H. Schwenke ; I. Gürtler ; P. K Stner ; M. A. Peters ; C. Iking-Konert [Allemagne]FRI0233 Tocilizumab administered in daily clinical practice - final results of the german non-interventional study “routine”
000605 (2013) P. Ostojic ; N. Damjanov ; A. Dimic ; D. Stefanovic ; M. Lazarevic ; T. Ilic [Serbie] ; S. ZivojinovicAB0566 Improved efficacy of rituximab in rheumatoid arthritis when administered regularly at six-month intervals – data from the serbian registry (NARASS)
000679 (2013) M. Schiff [États-Unis] ; R. Alten [Allemagne] ; M. Weinblatt [États-Unis] ; P. Nash [Australie] ; R. Fleischmann [États-Unis] ; P. Durez [Belgique] ; J. Kaine ; I. Delaet ; S. Kelly ; M. Maldonado ; S. Patel ; M. Genovese [États-Unis]AB0323 Weekly subcutaneous abatacept confers comparable onset of treatment response and magnitude of efficacy improvement over 6 months when administered with or without an intravenous abatacept loading dose
000807 (2013) R. Fleischmann [États-Unis] ; S. Fiore ; C. Fan ; D. Thompson [États-Unis]SAT0136 Sarilumab, a Fully Human Mab Against IL-6R Alpha, Subcutaneously-Administered Shows Significant Improvement in Ra Patients as Early as 2 Weeks: A Time to Event Analysis for Acr50 and Eular Good Response
000817 (2010) Afshin Borhani Haghighi [Iran] ; Anahid Safari [Iran]Proposing an algorithm for treatment of different manifestations of neuro-Behcet’s disease
000874 (2012) Ti Wen [République populaire de Chine] ; Yangguang Li [République populaire de Chine] ; Meng Wu [République populaire de Chine] ; Xiaolin Sun [République populaire de Chine] ; Xiucong Bao [République populaire de Chine] ; Yuquan Lin [République populaire de Chine] ; Jianlei Hao [République populaire de Chine] ; Lin Han [République populaire de Chine] ; Guangchao Cao [République populaire de Chine] ; Ziwen Wang [République populaire de Chine] ; Yuxiu Liu [République populaire de Chine] ; Zhenzhou Wu [République populaire de Chine] ; Zhangyong Hong [République populaire de Chine] ; Puyue Wang [République populaire de Chine] ; Liqing Zhao [République populaire de Chine] ; Zhanguo Li [République populaire de Chine] ; Qingmin Wang [République populaire de Chine] ; Zhinan Yin [République populaire de Chine]Therapeutic effects of a novel tylophorine analog, NK‐007, on collagen‐induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "administered" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "administered" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    administered
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021